Opioid Manufacturer Indivior’s Chief Executive Officer Pleads Guilty in Connection with Drug Safety Claims
Date of publication: 01-07-2020
FDA OCI, Shaun Thaxter, CEO, Indivior, guilty plea, opioid, Suboxone Film, misbranded, Reckitt Benckiser, recovery, addicts, marketing, withdrawal, treatment, buprenorphine, sales, preferred drug status, false information, misleading information Źródło: http://www.fda.gov
